Skip to main content
OpenTrials
Completed

NCT Number: NCT05113199

Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer

The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the Virtual Dignity Therapy intervention to palliative care patients with advanced cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

About this study

This study is an investigator-initiated, single site Mayo Clinic Rochester prospective minimal risk pilot study to determine feasibility and acceptability of Virtual Dignity Therapy. The Dignity Therapy intervention is a brief, individualized psychotherapy that aims to relieve psycho-emotional and existential distress and improve the experiences of patients whose lives are impacted by serious illness. This therapy offers patients an opportunity to reflect on their life with a trained facilitator and share their thoughts and memories with family and other people in their life. This therapy consists of a total of 3 sessions, with each session 2-4 weeks apart, in which the investigator provides questions focused on life review. The sessions are recorded and transcribed. The interventionist will work with patients to edit the document and provide a final generativity document for patient to keep and give to loved ones.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • English fluency
  • No diagnosed dementia
  • Diagnosis of advanced cancer
  • Expected prognosis > 6 months
  • Provide informed consent
  • Ability to complete questionnaire(s) by themselves or with assistance

Exclusion criteria

  • Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
  • Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months
  • Active delirium
  • Participation in concurrent legacy offerings through the palliative care clinic

Inclusion criteria

for caregivers:

  • Age ≥18 years
  • English fluency
  • Provide informed consent
  • Supported patient through Dignity Therapy

Treatment and study plan

Virtual Dignity Therapy

Behavioral

Virtual Dignity Therapy will be facilitated by a registered nurse or medical doctor trained in Dignity Therapy.

Primary outcomes

  1. Feasibility Number

    Time frame: 2 Years

    Study feasibility will be measured by the number of participants who enrolled and finished the study.

  2. Acceptability

    Time frame: Week 8 (after 3rd intervention session)

    Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Feasibility and Acceptability of Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Nov 9, 2021
Registry last updated
Mar 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.